Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages n/a-n/a
Publisher
Wiley
Online
2013-06-01
DOI
10.1002/ijc.28296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
- (2012) S. J. Advani et al. CLINICAL CANCER RESEARCH
- Enhancement of radiation response with bevacizumab
- (2012) Tien Hoang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncolytic Vaccinia virus and radiotherapy in head and neck cancer
- (2012) D. Mansfield et al. ORAL ONCOLOGY
- 1258 POSTER Phase I Clinical Trial of a Genetically Modified Oncolytic Vaccinia Virus GL-ONC1 With Green Fluorescent Protein Imaging
- (2011) A. Biondo et al. EUROPEAN JOURNAL OF CANCER
- Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
- (2011) Nanhai G Chen et al. Journal of Translational Medicine
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) R. Stupp et al. ANNALS OF ONCOLOGY
- Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil
- (2010) Franz J. Zemp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation
- (2010) Adrianne L. Myers et al. JOURNAL OF PEDIATRIC SURGERY
- A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer
- (2010) C. G. Willett et al. ONCOLOGIST
- Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis
- (2010) Inês Sofia Vala et al. PLoS One
- Unknown
- (2009) Nanhai Chen et al. MOLECULAR MEDICINE
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy
- (2009) A. Frentzen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment
- (2008) Stephanie Weibel et al. CELLULAR MICROBIOLOGY
- Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
- (2008) K. Twigger et al. CLINICAL CANCER RESEARCH
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started